Megaoesophagus Seconday to Myasthenia Gravis in Three Dogs

중증근무력증에 의한 개의 거대식도증 3례

  • Lee, Hee-Chun (Reserch Institute of Life Sciences, Gyeongsang National University) ;
  • Jeon, Joon-Hyeok (Reserch Institute of Life Sciences, Gyeongsang National University) ;
  • Cho, Kyu-Woan (Reserch Institute of Life Sciences, Gyeongsang National University) ;
  • Kang, Byeong-Teck (Laboratory of Veterinary Dermatology and Neurology, College of Veterinary Medicine, Chungbuk National University) ;
  • Jung, Dong-In (Reserch Institute of Life Sciences, Gyeongsang National University)
  • 이희천 (경상대학교 생명과학연구원) ;
  • 전준혁 (경상대학교 생명과학연구원) ;
  • 조규완 (경상대학교 생명과학연구원) ;
  • 강병택 (충북대학교 수의과대학) ;
  • 정동인 (경상대학교 생명과학연구원)
  • Accepted : 2011.10.14
  • Published : 2012.02.29

Abstract

Three dogs (An 8 years-old intact female Poodle, a 7 years-old intact male Schunauzer, and an 8 yearsold Golden Retriever) were presented due to acute vomiting, dyspnea, and generalized weakness. Megaesophagus was confirmed through radiographic examination in all 3 dogs. Relative oesophageal diameter (ROD) was measured and results of ROD measurements showed the possibility of megaesophagus secondary to myasthenia gravis in three dogs. Thus we performed anticholinesterase test as screening test for myasthenia gravis. In all three dogs, esophageal diameter was reduced after neostigmine methylsulfate administration. For definite diagnosis of acquired myasthenia gravis, serum acetylcholine receptor antibody titer was measured, but definite diagnosis was confirmed only in one case. However, based on history, radiographic findings, anticholinesterase test, ROD measurement, other two cases were still suspected as megaesophagus secondary to myasthenia gravis. Treatment with pyridostigmine bromide was initiated in all dogs, and improvement of esophageal diameter was shown in all dogs. One dog was successfully managed for 15 months after initial treatment and, is still alive, but other two dogs were died shortly after initial treatment, because of severe aspiration pneumonia.

Keywords

References

  1. Engel AG. Myasthenia gravis and myasthenic syndromes. Annals of Neurology 1984; 16: 519-534. https://doi.org/10.1002/ana.410160502
  2. Etinger SJ, Feldman EC. Myasthenia gravis: Peripheral nerve disorders. In: Textbook of veterinary internal medicine, 6th ed. St. Louis: Elsevier Saunders. 2005: 895-896.
  3. Dewey CW. Myasthenia gravis: Disorders of the neuromuscular junction. In: A practical guide to canine & feline neurology, 2nd ed. Ames: Willey Blackwell. 2008: 527-528.
  4. Kang BT, Jung DI, Park HM. Acute fulminating myasthenia gravis in a shih-tzu dog. J Vet Clin 2006; 23: 465-468.
  5. Lennon VA, Palmer AC, Pflugfelder C, Indrieri RJ. Myasthenia gravis in dogs. In: Genetic Control of Autoimmune disease. Amsterdam: Elsevier. 1978: 295-306.
  6. Lennon VA, Lambert EH, Palmer AC, Cunningham JG, Christie TR. Acquired and congenital myasthenia gravis in dogs: A study of 20 cases. In: Myasthenia Gravis - Pathogenesis and treatment. Tokyo: Tokyo university press. 1981: 41-54.
  7. Lindstrom J, Shelton GD, Fujii Y. Myasthenia gravis. Advances in immunology 1988; 42: 233-284.
  8. Oda K, Lambert EH, Lennon VA, Palmer AC. Congenital canine myasthenia gravis: I. Deficient junctional acetylcholine receptors. Muscle and Nerve 1984; 7: 705-716. https://doi.org/10.1002/mus.880070904
  9. Oda K, Lambert EH, Lennon VA, Palmer AC. Congenital canine myasthenia gravis: II. Acetylcholine receptor metabolism. Muscle and Nerve 1984; 7: 717-724. https://doi.org/10.1002/mus.880070905
  10. Shelton GD, Willard MD, Cardinet GH III, Lindstrom J. Acquired myasthenia gravis. Selective involvement of oesophageal, pharyngeal and facial muscles. J Vet Intern Med 1990; 4: 281-284. https://doi.org/10.1111/j.1939-1676.1990.tb03124.x
  11. Shelton GD. Myasthenia gravis and disorders of neuromuscular transmission. Veterinary Clinics of North America: Small Animal Practice 2002; 32: 189-206. https://doi.org/10.1016/S0195-5616(03)00085-8
  12. Silverstein DC, Hopper K. Lower motor neuron disease. In: Small animal critical care medicine, 1st ed. St. Louis: Elsevier Saunders. 2009: 433-434.
  13. Wray JD, Sparkes AH. Use of radiographic measurements in distinguishing myasthenia gravis from other causes of canine megaoesophagus. J Small Anim Pract 2006; 47: 256-263. https://doi.org/10.1111/j.1748-5827.2006.00015.x
  14. Yam PS, Shelton GD, Simpson JW. Megaoesophagus secondary to acquired myasthenia gravis. J Small Anim Prac 1996; 37: 179-183. https://doi.org/10.1111/j.1748-5827.1996.tb01957.x